Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$14.06 - $16.79 $174,344 - $208,196
-12,400 Reduced 27.62%
32,500 $510,000
Q4 2023

Feb 14, 2024

SELL
$11.67 - $20.73 $630 - $1,119
-54 Reduced 0.12%
44,900 $726,000
Q3 2023

Nov 14, 2023

SELL
$12.15 - $17.85 $861,301 - $1.27 Million
-70,889 Reduced 61.19%
44,954 $552,000
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $17,526 - $24,648
1,243 Added 1.08%
115,843 $1.86 Million
Q1 2023

May 15, 2023

SELL
$9.09 - $19.45 $1.42 Million - $3.04 Million
-156,400 Reduced 57.71%
114,600 $2 Million
Q4 2022

Feb 14, 2023

SELL
$6.45 - $12.07 $2.62 Million - $4.9 Million
-406,199 Reduced 59.98%
271,000 $2.5 Million
Q3 2022

Nov 14, 2022

SELL
$7.86 - $12.91 $6.15 Million - $10.1 Million
-782,858 Reduced 53.62%
677,199 $5.83 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $4.26 Million - $8.44 Million
604,070 Added 70.57%
1,460,057 $11.9 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $10.4 Million - $30.2 Million
855,987 New
855,987 $10.4 Million
Q2 2019

Aug 14, 2019

SELL
$19.57 - $24.1 $1.44 Million - $1.78 Million
-73,821 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$12.14 - $20.46 $6.24 Million - $10.5 Million
-513,846 Reduced 87.44%
73,821 $1.51 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $164,092 - $270,081
-14,599 Reduced 2.42%
587,667 $7.41 Million
Q3 2018

Nov 14, 2018

SELL
$12.5 - $15.38 $3.31 Million - $4.07 Million
-264,621 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $2.11 Million - $3.72 Million
264,621 New
264,621 $3.47 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.82B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.